Advance your academic career, collaborate globally, and expand your network— join now !

Ramon Eritja

Prof. Ramon Eritja

IQAC-CSIC, CIBER-BBN

Share Link

Share

Information

Dr. Ramon Eritja is Research Professor of the Nucleic Acids Chemistry group at the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC). He obtained his PhD in chemistry from the University of Barcelona (UB) in 1983. He was postdoctoral fellow in Dr. Itakura’s (Beckman Research Institute at City of Hope, USA, 1984-1988) and Dr. Caruthers’s (University of Colorado at Boulder, USA, 1988-1989) laboratories. He moved to UB, (1989-1990) and CSIC, Barcelona (1990-1994). He was Group Leader at EMBL, Germany (1994-1999). He returned to CSIC, Barcelona (1999) and he was invited member at the IRB Barcelona, 2006-2012) and selected as member of the Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) since 2006. He was Director of IQAC (2012-2017). His research interests are centred on the synthesis and properties of nucleic acids derivatives including siRNA, antisense, aptamers, oligonucleotide conjugates and DNA nanotechnology.

Research Keywords & Expertise

Oligonucleotide Synthe...
RNA interference
DNA aptamers
DNA Origami
G-quadruplex

Short Biography

Dr. Ramon Eritja is Research Professor of the Nucleic Acids Chemistry group at the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC). He obtained his PhD in chemistry from the University of Barcelona (UB) in 1983. He was postdoctoral fellow in Dr. Itakura’s (Beckman Research Institute at City of Hope, USA, 1984-1988) and Dr. Caruthers’s (University of Colorado at Boulder, USA, 1988-1989) laboratories. He moved to UB, (1989-1990) and CSIC, Barcelona (1990-1994). He was Group Leader at EMBL, Germany (1994-1999). He returned to CSIC, Barcelona (1999) and he was invited member at the IRB Barcelona, 2006-2012) and selected as member of the Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) since 2006. He was Director of IQAC (2012-2017). His research interests are centred on the synthesis and properties of nucleic acids derivatives including siRNA, antisense, aptamers, oligonucleotide conjugates and DNA nanotechnology.